WP
AMPE

WealthPLAN Partners’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

WealthPLAN Partners’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-8
Closed -$39 – 1430
2023
Q1 		$39 Buy
+8
New +$45 ﹤0.01% 1306
2022
Q1 		$3K Hold
48
– – ﹤0.01% 382
2021
Q4 		$7K Hold
48
– – ﹤0.01% 380
2021
Q3 		$15K Hold
48
– – ﹤0.01% 371
2021
Q2 		$21K Hold
48
– – ﹤0.01% 355
2021
Q1 		$28K Hold
48
– – ﹤0.01% 332
2020
Q4 		$28K Hold
48
– – ﹤0.01% 332
2020
Q3 		$12K Hold
48
– – ﹤0.01% 314
2020
Q2 		$12K Hold
48
– – ﹤0.01% 308
2020
Q1 		$8K Sell
48
-50
-51% -$9.05K ﹤0.01% 254
2019
Q4 		$19K Buy
+98
New +$12.7K ﹤0.01% 245

Other funds holding AMPE

HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $5.38B AUM 27.31% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $3.06B AUM 26.31% 1-Year Est. Return
IWM
IHT Wealth Management Chicago, Illinois $4.7B AUM 25.67% 1-Year Est. Return
CC
Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

WealthPLAN Partners's AMPE Position: Q2 2023 in Review

WealthPLAN Partners sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2023, closing a stake of 8 shares — an estimated $39 sold.

WealthPLAN Partners first reported a position in AMPE in Q4 2019 and held it in 11 quarters. The position peaked at $28K in Q1 2021. 34 funds tracked by Wall St. Rank hold AMPE as of Q2 2023.

  • WealthPLAN Partners reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2023 after selling out during the quarter.
  • WealthPLAN Partners sold 8 Ampio Pharmaceuticals Inc. shares in Q2 2023, an estimated $39.
  • WealthPLAN Partners first reported a position in Ampio Pharmaceuticals Inc. in Q4 2019 and held it in 11 quarters.
  • WealthPLAN Partners's Ampio Pharmaceuticals Inc. position peaked at $28K in Q1 2021.
  • 34 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2023.

Based on WealthPLAN Partners's 13F filing for Q2 2023, filed 31 Jul 2023.